Matthew is a Regulatory Consultant at Blue Frog Scientific, specialising in EU and UK biocides regulation, with experience supporting companies through the Biocidal Products Regulation (BPR) and national registrations under the transitional agreement during BPR implementation. In his role, Matthew liaises directly with clients, manages and delivers regulatory projects, and provides technical support across associated initiatives.
Before joining Blue Frog Scientific, Matthew spent 10 years in the fast-moving consumer goods sector, with five years focused on regulatory strategy and operations for biocidal and disinfectant products on a global scale. He led the delivery and submission of a large Biocidal Product Family dossier through Union Authorisation and managed responses to Competent Authority questions throughout the evaluation process up to approval. His experience in a large multinational environment involved translating complex project requirements into actionable deliverables for cross-functional teams across multiple regions.
Matthew’s regulatory focus has included product types 1, 2 and 4, primarily for consumer use, with experience engaging directly with ECHA and EU Competent Authorities, including Latvia and Germany, under BPR. Under transitional rules, he has supported complex national biocidal registration regimes across Europe, including Belgium, the Netherlands, and Greece, aiming to achieve product approvals while minimising costs and avoiding lengthy product testing.
Previously, Matthew was an active member of AISE’s Biocides Working Group, providing feedback on draft guidance and contributing to industry-friendly developments. He takes a pragmatic, solutions-driven approach to regulatory challenges, balancing legislative requirements with practical commercial considerations.
